PMS47 The Long Term Cost-Effectiveness of Golimumab for the Treatment of Severe, Active Ankylosing Spondylitis in Adults Who Have Responded Inadequately to Conventional Therapy
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.433
https://www.valueinhealthjournal.com/article/S1098-3015(11)01995-4/fulltext
Title :
PMS47 The Long Term Cost-Effectiveness of Golimumab for the Treatment of Severe, Active Ankylosing Spondylitis in Adults Who Have Responded Inadequately to Conventional Therapy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01995-4&doi=10.1016/j.jval.2011.08.433
First page :
A311
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
406